Novel design and in silico optimization of 5-azaquinazoline-based IRAK4 inhibitors using qsar, docking, pharmacokinetics, and molecular dynamics for diffuse large B-Cell lymphoma
2025In Silico Research in BiomedicineJournalOpen access
10.1016/j.insi.2025.100047Full text11 citations